InvestLog
MDCX Medicus Pharma Ltd. Common Stock logo

MDCX Medicus Pharma Ltd. Common Stock

Healthcare
$0.30+4.90%ClosedMarket Cap: $6.6M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

6.68

P/S

0.00

EV/EBITDA

-0.01

DCF Value

$0.08

FCF Yield

-354.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-4086.3%

ROA

-497.3%

ROIC

-2193.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$0.00$-6.6M$—
Q4 null$0.00$-8.2M$—
FY null$0.00$-25.4M$—
Q3 null$0.00$-16.0M$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell
D. Boral CapitalBuy
2026-04-20
D. Boral CapitalBuy
2026-03-19
D. Boral CapitalBuy
2025-12-15
D. Boral CapitalBuy
2025-11-13
D. Boral CapitalBuy
2025-09-29

Trading Activity

Insider Trades

View All
Smith Andrew Alasdairofficer: Chief Operating Officer
SellWed Apr 01
Rodgers Cathy McMorrisdirector
SellWed Apr 01
Raju Ajaydirector
SellWed Apr 01
Mehmud Faisalofficer: Chief Medical Officer
SellWed Apr 01
May Sara R.director
SellWed Apr 01

Latest News

Medicus Pharma gives Teverelix Phase 2 FDA update – ICYMIProactive Investors · Fri Apr 10

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

CA

Exchange

—

Beta

-0.85

Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.

Peers

ALGS logoALGSBRNS logoBRNSCOEP logoCOEPCUE logoCUECVM logoCVMINMB logoINMBIPSC logoIPSCKPTI logoKPTISKYE logoSKYETELO logoTELO